{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:30:57Z","timestamp":1763037057910},"reference-count":42,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background:<\/jats:title><jats:p>Neurofibromatosis type 1 (NF1) is a multisystem disorder characterized by progressive manifestations, which is inherited in an autosomal dominant manner. The majority of patients with NF1 experience a diffuse, significant reduction in bone mass over time, with osteoporosis, osteopenia in the absence of severe scoliosis, or gross bone deformities. This study aimed to determine the bone mineral density (BMD) status, evaluate bone metabolism, and to determine the relevant factors in children with NF1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The study population included 33 pediatric NF1 patients (20 males and 13 females). Bone metabolic markers, such as total calcium, phosphorus, magnesium, alkaline phosphatase, parathyroid hormone, and 25-OH vitamin D, the urinary calcium\/creatine ratio were measured. In addition, BMD was measured at both the lumbar spine (LS) and the femoral neck in all the patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>All the patients had a low 25-OH vitamin D level, but it was significantly lower in the females than in the males (p&lt;0.009). Overall, 18.2% of the patients had skeletal abnormalities. The lumbar Z-score was \u22642 in 21.2% of the patients, whereas the femoral neck Z-score was \u22642 in 9.1%. The urinary calcium\/creatine ratio was significantly higher in the female than in the male patients (p&lt;0.027). In all, six patients had skeletal abnormalities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>It is widely known that bone mineral metabolism markers and BMD are significantly affected in NF1 patients; however, the present study did not identify any effective parameters that could be used to predict skeletal abnormalities, or diagnose early osteoporosis and osteopenia in pediatric NF1 patients.<\/jats:p><\/jats:sec>","DOI":"10.1515\/jpem-2016-0092","type":"journal-article","created":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T10:01:27Z","timestamp":1485424887000},"source":"Crossref","is-referenced-by-count":23,"title":["Bone mineral density and bone metabolic markers\u2019 status in children with neurofibromatosis type 1"],"prefix":"10.1515","volume":"30","author":[{"given":"Hatice Gamze","family":"Poyrazo\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veysel Nijat","family":"Ba\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Bastug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Canpolat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"Per","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"G\u00fcm\u00fcs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sefer","family":"Kumandas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref281","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.bpb.0000271310.87997.ae","article-title":"Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort","volume":"27","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00198-009-0933-y","article-title":"High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1","volume":"21","year":"2010","journal-title":"Osteoporos Int"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jocd.2005.08.001","article-title":"Bone mineral density of healthy Turkish children and adolescents","volume":"9","year":"2006","journal-title":"J Clin Densitom"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"e86115","DOI":"10.1371\/journal.pone.0086115","article-title":"Multiscale, converging defects of macro-porosity microstructure and matrix mineralization impact long bone fragility in NF1","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/hmg\/ddl208","article-title":"Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem\/progenitor cells","volume":"15","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s001980170032","article-title":"Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities","volume":"12","year":"2001","journal-title":"Osteoporos Int"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF- 1 tumor suppressor gene function: narrowing the GAP","volume":"104","year":"2001","journal-title":"Cell"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jocd.2005.08.001","article-title":"Bone mineral density of healthy Turkish children and adolescents","volume":"9","year":"2006","journal-title":"J Clin Densitom"},{"key":"ref41","first-page":"111","article-title":"Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1)","volume":"13","year":"2013","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF- 1 tumor suppressor gene function: narrowing the GAP","volume":"104","year":"2001","journal-title":"Cell"},{"key":"ref01","first-page":"994","article-title":"Neurofibromatosis and related tumors. Natural occurrence and animal models","volume":"145","year":"1994","journal-title":"Am J Pathol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-005-1940-2","article-title":"Decreased bone mineral density in patients with neurofibromatosis 1","volume":"16","year":"2005","journal-title":"Osteoporos Int"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI29092","article-title":"Hyperactivation of p 21ras and p13k cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions","volume":"116","year":"2006","journal-title":"J Clin Invest"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2007.12.004","article-title":"Generalized metabolic bone disease in Neurofibromatosis type I","volume":"94","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00198-004-1801-4","article-title":"Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body","volume":"16","year":"2005","journal-title":"Osteoporosis Int"},{"key":"ref221","first-page":"994","article-title":"Neurofibromatosis and related tumors. Natural occurrence and animal models","volume":"145","year":"1994","journal-title":"Am J Pathol"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.braindev.2008.02.002","article-title":"Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1","volume":"30","year":"2008","journal-title":"Brain Dev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003086-200208000-00013","article-title":"Orthopaedic manifestations of neurofibromatosis in children: an update","volume":"401","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/hmg\/ddl208","article-title":"Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem\/progenitor cells","volume":"15","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00403-011-1191-3","article-title":"Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklinghausen disease)","volume":"304","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jmg.2006.041095","article-title":"Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1","volume":"43","year":"2006","journal-title":"J Med Genet"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s001980170032","article-title":"Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities","volume":"12","year":"2001","journal-title":"Osteoporos Int"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpeds.2006.10.048","article-title":"Bone mineral density in children and adolescents with neurofibromatosis type 1","volume":"150","year":"2007","journal-title":"J Pediatr"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-005-1940-2","article-title":"Decreased bone mineral density in patients with neurofibromatosis 1","volume":"16","year":"2005","journal-title":"Osteoporos Int"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.braindev.2008.02.002","article-title":"Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1","volume":"30","year":"2008","journal-title":"Brain Dev"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jmg.2006.041095","article-title":"Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1","volume":"43","year":"2006","journal-title":"J Med Genet"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","year":"1997","journal-title":"J Am Med Assoc"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00198-009-0933-y","article-title":"High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1","volume":"21","year":"2010","journal-title":"Osteoporos Int"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1651-2227.2007.00401.x","article-title":"Bone mineral density in children with neurofibromatosis 1","volume":"96","year":"2007","journal-title":"Acta Paediatr"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00198-004-1801-4","article-title":"Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body","volume":"16","year":"2005","journal-title":"Osteoporosis Int"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5435\/00124635-199907000-00002","article-title":"Neurofibromatosis in children: the role of orthopaedist","volume":"7","year":"1999","journal-title":"J Am Acad Orthop Surg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2007.12.004","article-title":"Generalized metabolic bone disease in Neurofibromatosis type I","volume":"94","year":"2008","journal-title":"Mol Genet Metab"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpeds.2006.10.048","article-title":"Bone mineral density in children and adolescents with neurofibromatosis type 1","volume":"150","year":"2007","journal-title":"J Pediatr"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI29092","article-title":"Hyperactivation of p 21ras and p13k cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions","volume":"116","year":"2006","journal-title":"J Clin Invest"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5435\/00124635-199907000-00002","article-title":"Neurofibromatosis in children: the role of orthopaedist","volume":"7","year":"1999","journal-title":"J Am Acad Orthop Surg"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00403-011-1191-3","article-title":"Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklinghausen disease)","volume":"304","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.bpb.0000271310.87997.ae","article-title":"Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort","volume":"27","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003086-200208000-00013","article-title":"Orthopaedic manifestations of neurofibromatosis in children: an update","volume":"401","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","year":"1997","journal-title":"J Am Med Assoc"},{"key":"ref261","first-page":"111","article-title":"Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1)","volume":"13","year":"2013","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"e86115","DOI":"10.1371\/journal.pone.0086115","article-title":"Multiscale, converging defects of macro-porosity microstructure and matrix mineralization impact long bone fragility in NF1","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1651-2227.2007.00401.x","article-title":"Bone mineral density in children with neurofibromatosis 1","volume":"96","year":"2007","journal-title":"Acta Paediatr"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2017.30.issue-2\/jpem-2016-0092\/jpem-2016-0092.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0092\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:40:48Z","timestamp":1619055648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0092\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":42,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2016-0092","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,1]]}}}